Record Information |
---|
Version | 2.0 |
---|
Created at | 2021-01-06 06:50:28 UTC |
---|
Updated at | 2021-07-15 17:36:38 UTC |
---|
NP-MRD ID | NP0021548 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Negamycin |
---|
Provided By | NPAtlas |
---|
Description | Negamycin is found in Streptomyces and Streptomyces No. M890-C2. Negamycin was first documented in 1971 (PMID: 5121145). Based on a literature review very few articles have been published on 2-({[(3R,5R)-3,6-diamino-1,5-dihydroxyhexylidene]amino}(methyl)amino)acetic acid (PMID: 33468467) (PMID: 31620232) (PMID: 31159660) (PMID: 29497617). |
---|
Structure | [H]OC(=O)C([H])([H])N(N([H])C(=O)C([H])([H])[C@]([H])(N([H])[H])C([H])([H])[C@@]([H])(O[H])C([H])([H])N([H])[H])C([H])([H])[H] InChI=1S/C9H20N4O4/c1-13(5-9(16)17)12-8(15)3-6(11)2-7(14)4-10/h6-7,14H,2-5,10-11H2,1H3,(H,12,15)(H,16,17)/t6-,7-/m1/s1 |
---|
Synonyms | Value | Source |
---|
2-({[(3R,5R)-3,6-diamino-1,5-dihydroxyhexylidene]amino}(methyl)amino)acetate | Generator | (2-((3R,5R)-3,6-diamino-5-Hydroxyhexanoyl)-1-methylhydrazino) acetic acid | MeSH | Negamycin, (threo-D)-isomer | MeSH |
|
---|
Chemical Formula | C9H20N4O4 |
---|
Average Mass | 248.2795 Da |
---|
Monoisotopic Mass | 248.14846 Da |
---|
IUPAC Name | 2-[(3R,5R)-3,6-diamino-5-hydroxy-N'-methylhexanehydrazido]acetic acid |
---|
Traditional Name | [(3R,5R)-3,6-diamino-5-hydroxy-N'-methylhexanehydrazido]acetic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | CN(CC(O)=O)NC(=O)C[C@H](N)C[C@@H](O)CN |
---|
InChI Identifier | InChI=1S/C9H20N4O4/c1-13(5-9(16)17)12-8(15)3-6(11)2-7(14)4-10/h6-7,14H,2-5,10-11H2,1H3,(H,12,15)(H,16,17)/t6-,7-/m1/s1 |
---|
InChI Key | IKHFJPZQZVMLRH-RNFRBKRXSA-N |
---|
Experimental Spectra |
---|
|
| Not Available | Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | Species Name | Source | Reference |
---|
Streptomyces | NPAtlas | | Streptomyces No. M890-C2 | Bacteria | |
|
---|
Species Where Detected | |
---|
Chemical Taxonomy |
---|
Description | This compound belongs to the class of organic compounds known as beta amino acids and derivatives. These are amino acids having a (-NH2) group attached to the beta carbon atom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Beta amino acids and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Beta amino acid or derivatives
- Alpha-amino acid or derivatives
- 1,3-aminoalcohol
- 1,2-aminoalcohol
- Amino acid
- Secondary alcohol
- Carboxylic acid hydrazide
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Organic nitrogen compound
- Organonitrogen compound
- Primary aliphatic amine
- Organooxygen compound
- Primary amine
- Carbonyl group
- Hydrocarbon derivative
- Amine
- Organic oxide
- Alcohol
- Organic oxygen compound
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Kondo S, Shibahara S, Takahashi S, Maeda K, Umezawa H: Negamycin, a novel hydrazide antibiotic. J Am Chem Soc. 1971 Nov;93(23):6305-6. doi: 10.1021/ja00752a072. [PubMed:5121145 ]
- Horompoli D, Ciglia C, Glusenkamp KH, Haustedt LO, Falkenstein-Paul H, Bendas G, Berscheid A, Brotz-Oesterhelt H: The Antibiotic Negamycin Crosses the Bacterial Cytoplasmic Membrane by Multiple Routes. Antimicrob Agents Chemother. 2021 Mar 18;65(4). pii: AAC.00986-20. doi: 10.1128/AAC.00986-20. Print 2021 Mar 18. [PubMed:33468467 ]
- Hamada K, Omura N, Taguchi A, Baradaran-Heravi A, Kotake M, Arai M, Takayama K, Taniguchi A, Roberge M, Hayashi Y: New Negamycin-Based Potent Readthrough Derivative Effective against TGA-Type Nonsense Mutations. ACS Med Chem Lett. 2019 Sep 23;10(10):1450-1456. doi: 10.1021/acsmedchemlett.9b00273. eCollection 2019 Oct 10. [PubMed:31620232 ]
- Hamada K, Naito A, Hamaguchi Y, Kanesaki Y, Kasahara K, Taguchi A, Omura N, Hayashi Y, Usui T: Ubr1p-Cup9p-Ptr2p pathway involves in the sensitivity to readthrough compounds negamycin derivatives in budding yeast. Biosci Biotechnol Biochem. 2019 Oct;83(10):1889-1892. doi: 10.1080/09168451.2019.1625263. Epub 2019 Jun 4. [PubMed:31159660 ]
- Pranke I, Bidou L, Martin N, Blanchet S, Hatton A, Karri S, Cornu D, Costes B, Chevalier B, Tondelier D, Girodon E, Coupet M, Edelman A, Fanen P, Namy O, Sermet-Gaudelus I, Hinzpeter A: Factors influencing readthrough therapy for frequent cystic fibrosis premature termination codons. ERJ Open Res. 2018 Feb 23;4(1). pii: 00080-2017. doi: 10.1183/23120541.00080-2017. eCollection 2018 Jan. [PubMed:29497617 ]
|
---|